Shire PLC (LON:SHP)‘s stock had its “outperform” rating reaffirmed by equities researchers at Royal Bank of Canada in a note issued to investors on Monday.

Other analysts also recently issued research reports about the company. Bryan, Garnier & Co reaffirmed a “buy” rating and issued a GBX 6,800 ($85.59) price objective on shares of Shire PLC in a research note on Monday, December 5th. Deutsche Bank AG reissued a “buy” rating and set a GBX 6,300 ($79.30) target price on shares of Shire PLC in a research report on Monday, December 5th. Shore Capital reissued a “buy” rating on shares of Shire PLC in a research report on Thursday, January 5th. Jefferies Group LLC reissued a “buy” rating and set a GBX 6,600 ($83.07) target price on shares of Shire PLC in a research report on Thursday, January 5th. Finally, Liberum Capital reissued a “buy” rating and set a GBX 5,500 ($69.23) target price on shares of Shire PLC in a research report on Thursday, December 22nd. One research analyst has rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of GBX 6,115.60 ($76.97).

Analyst Recommendations for Shire PLC (LON:SHP)

Shire PLC (LON:SHP) opened at 4497.50 on Monday. The company’s market capitalization is GBX 40.60 billion. Shire PLC has a 12-month low of GBX 2,707.19 and a 12-month high of GBX 5,377.00. The firm has a 50-day moving average of GBX 4,716.00 and a 200 day moving average of GBX 4,710.64.

The company also recently announced a dividend, which will be paid on Tuesday, April 25th. Shareholders of record on Thursday, March 9th will be issued a GBX 20.64 ($0.26) dividend. This represents a dividend yield of 0.43%. This is a boost from Shire PLC’s previous dividend of $3.51. The ex-dividend date of this dividend is Thursday, March 9th.

WARNING: “Shire PLC (SHP) Stock Rating Reaffirmed by Royal Bank of Canada” was posted by Marea Informative and is owned by of Marea Informative. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at http://www.mareainformativa.com/royal-bank-de-canada-reitera-superar-la-calificacion-de-shire-plc-shp/108857/.

In other news, insider William Burns bought 136 shares of the stock in a transaction on Friday, March 31st. The stock was acquired at an average cost of GBX 4,742 ($59.69) per share, for a total transaction of £6,449.12 ($8,117.21).

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.